Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
about
Molecular alterations in gastric cancer with special reference to the early-onset subtypeStrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review.BET inhibition as a new strategy for the treatment of gastric cancer.Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomibGenetic amplification of PPME1 in gastric and lung cancer and its potential as a novel therapeutic target.HER2 therapies and gastric cancer: a step forward.Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancerScreening endoscopy finds high prevalence of Helicobacter pylori and intestinal metaplasia in Korean American with limited access to health care.Effects of carboxypeptidase B treatment and elevated temperature on recombinant monoclonal antibody charge variants in cation-exchange chromatography analysis.Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy.Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric AdenocarcinomaMonoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy.Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches.Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.Genetics of gastric cancer.Outlooks on Epstein-Barr virus associated gastric cancer.Phase II study of trastuzumab in combination with S-1 and cisplatin in the first-line treatment of human epidermal growth factor receptor HER2-positive advanced gastric cancer.Next generation sequencing-based emerging trends in molecular biology of gastric cancer.
P2860
Q26764919-76C49785-80F7-44F9-9BCD-57DCC110CC5BQ33679597-0B412845-0A5C-4951-8693-2F9AAB2BF1DBQ36015280-061AF642-D7EC-4F90-A456-B87527286647Q36040347-A4C23515-AD54-4E0F-B02D-7792F7896227Q36782473-D001B7E1-09FB-44E9-9C0B-FF6C7EC91C08Q37610073-4697B4E4-E5A3-47ED-9C9A-9E80930FC360Q38151672-EDE6C59B-40B1-4C2B-9BD9-BBC89E3705F0Q38997289-ED2EC16A-D6F5-4E73-AFF3-A7FB3FFF9930Q40226863-651D40B3-A727-430D-9CCC-90A69D63A832Q40622943-34E312D6-C260-4747-98E1-DC8A0D9C2BEDQ41571663-B3506EC4-A686-4110-A4FC-C4FBFA126478Q41601800-4AE000D8-FF49-40A4-A56F-F17FCF4AA0EBQ41718653-A46C0930-F9BD-45B1-8FD4-D39EB4E05D9BQ41807232-CE3AD992-EFB0-4F30-86A0-C25DD7FD2B45Q47102297-F6464BCB-D2FD-411F-ABE3-C24DAF6F635EQ49898050-70D7E3DC-9610-4F0E-B22A-AF628790BFE1Q51219045-32CF9275-6219-4B9E-BF34-BDD38C520265Q52720624-66CF9997-9CCA-40F7-A8C1-5E77DD01E9E6Q53458025-2EEA18EC-02DB-4530-8AB6-18BE97F9C245Q54261019-F5A26329-1DB7-4F02-9C1B-A8E969AA1F2B
P2860
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
@ast
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
@en
type
label
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
@ast
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
@en
prefLabel
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
@ast
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.
@en
P2093
P2860
P356
P1476
Gastric cancer and trastuzumab: first biologic therapy in gastric cancer
@en
P2093
Krishna S Gunturu
M Wasif Saif
Nike Beaubier
Yanghee Woo
P2860
P304
P356
10.1177/1758834012469429
P50
P577
2013-03-01T00:00:00Z